Lp(a) Tied to Higher CVD Events; Risk Reduction With IPE
New analysis of the REDUCE-IT trial suggested benefit of icosapent ethyl doesn't vary by Lp(a) level and confirmed risk for Lp(a) with high triglycerides but not cholesterol.
Medscape Medical News
source https://www.medscape.com/viewarticle/lp-tied-higher-cvd-events-risk-reduction-ipe-2024a10006d8?src=rss
Medscape Medical News
source https://www.medscape.com/viewarticle/lp-tied-higher-cvd-events-risk-reduction-ipe-2024a10006d8?src=rss
Comments
Post a Comment